Fig. 3From: The role of opioids in cancer response to immunotherapyImpact on survival outcomes of opioids in patients with bone metastases. Oncological patients who need opioids during immunotherapy have worse OS (a) and PFS (b) regardless of they have or have not bone metastasesBack to article page